Exposure to a first dose of the AstraZeneca COVID-19 vaccine (ChAdOx1) but not the Pfizer vaccine (BNT162b2) appears to be associated with a small increased risk of idiopathic thrombocytopenic purpura (ITP). An analysis of the first four months of the Scottish COVID-19 vaccination program, comprising 2.53 million people using data from linked databases, found ITP occurred ...
Small risk of ITP with AstraZeneca COVID-19 vax
By Mardi Chapman
15 Jun 2021